Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HydRx Farms is a Canadian cannabis and cannabinoid products company operating in Whitby, Ontario. The business has been described as a vertically integrated biopharmaceutical licensed dealer focused on developing, manufacturing, and commercializing pharmaceutical-grade cannabinoid derivative products, medical cannabis, and related nutraceutical or natural health products. Publicly available sources also associate the HydRx Farms name with Scientus Pharma Inc., suggesting HydRx functions as a brand or operating name rather than a distinct standalone biotech with a conventional drug-development pipeline. The company appears to be commercially active rather than a clinical-stage therapeutics developer, with emphasis on regulated production, processing, and distribution capabilities. Available evidence does not indicate a traditional pipeline of named drug candidates in Phase 1-3 clinical development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HydRx Farms.